1998
DOI: 10.1016/s0168-1605(98)00030-0
|View full text |Cite
|
Sign up to set email alerts
|

Phosphate group requirement for mitogenic activation of lymphocytes by an extracellular phosphopolysaccharide from Lactobacillus delbrueckii ssp. bulgaricus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
115
0
4

Year Published

2006
2006
2020
2020

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 190 publications
(123 citation statements)
references
References 18 publications
4
115
0
4
Order By: Relevance
“…EPSs produced by LAB have received increasing attention mainly because of their health benefits. Immune stimulation, antimutagenicity, and antitumor activity of fermented dairy products prepared with EPS-producing LAB or EPSs themselves have been investigated (Chabot et al, 2001;Kitazawa et al, 1998;Sreekmar and Hosono, 1998;Tsuda et al, 2008b). However, studies of applications using EPSs produced by LAB as prebiotics are limited.…”
Section: Introductionmentioning
confidence: 99%
“…EPSs produced by LAB have received increasing attention mainly because of their health benefits. Immune stimulation, antimutagenicity, and antitumor activity of fermented dairy products prepared with EPS-producing LAB or EPSs themselves have been investigated (Chabot et al, 2001;Kitazawa et al, 1998;Sreekmar and Hosono, 1998;Tsuda et al, 2008b). However, studies of applications using EPSs produced by LAB as prebiotics are limited.…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, this is supported further by evidence at the cellular level, as murine macrophages challenged with various EPSs (isolated from strains of lactobacilli and bifidobacteria) demonstrate augmented release of both pro-and anti-inflammatory cytokines, such as TNF-a, IL-6 and IL-10 (Chabot et al, 2001;Bleau et al, 2010;Wu et al, 2010). The mitogenic activity of EPSs isolated from strains of lactobacilli and bifidobacteria is also well characterized, with studies showing the promotion of human, murine, porcine and bovine macrophage proliferation (Kitazawa et al, 1998;Chabot et al, 2001;Wu et al, 2010).…”
Section: Exopolysaccharidesmentioning
confidence: 99%
“…Additionally, this is supported further by evidence at the cellular level, as murine macrophages challenged with various EPSs (isolated from strains of lactobacilli and bifidobacteria) demonstrate augmented release of both pro-and anti-inflammatory cytokines, such as TNF-a, IL-6 and IL-10 (Chabot et al, 2001;Bleau et al, 2010;Wu et al, 2010). The mitogenic activity of EPSs isolated from strains of lactobacilli and bifidobacteria is also well characterized, with studies showing the promotion of human, murine, porcine and bovine macrophage proliferation (Kitazawa et al, 1998;Chabot et al, 2001;Wu et al, 2010).With a large number of EPS-producing bacteria naturally residing in the intestine, it is surprising that very little research has been undertaken into the interaction of EPSs with the intestinal epithelial layer itself. Previous studies have investigated the potential of EPSs as antiproliferative or anticytoxic agents with intestinal epithelial cells (Ruas-Madiedo et al, 2010;Liu et al, 2011), but, the immunomodulatory effects of EPSs on these cells has largely been neglected in the literature.…”
mentioning
confidence: 99%
“…Examples of PAMP include cellular components such as zymosan and DNA motifs, which have been shown to activate TLR2 and TLR9 signaling pathways, respectively [46]. In previous studies, we showed that the PAMP from lactic acid bacteria (LAB) (e.g., cell wall components, extracellular phosphopolysaccharide, and CpG or non-CpG DNA motifs) have immunostimulatory activities, including augmentation of mitogenic activity, up-regulation of costimulatory molecule expression, and induction of cytokine production [17,23,24,35,45]. Furthermore, in recent studies, we revealed that immunobiotic LAB and their CpG or non-CpG DNA motifs are recognized by TLR2 and TLR9, respectively, and we also confirmed that NF-κB is activated in TLR2-or TLR9-expressing transfectants [37][38][39]47].…”
Section: Introductionmentioning
confidence: 99%